Dermatitis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dermatitis stocks.

Dermatitis Stocks Recent News

Date Stock Title
Nov 15 REGN FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
Nov 15 ARQT Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
Nov 15 REGN Regeneron, Sanofi say resubmitted application to expand Dupixent label accepted in U.S.
Nov 15 FBRX Forte Biosciences GAAP EPS of -$4.54
Nov 15 REGN Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
Nov 14 FBRX Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
Nov 14 REGN Citi initiates coverage on 5 new biotech stocks
Nov 14 APGE Apogee Therapeutics (NASDAQ:APGE) Is In A Good Position To Deliver On Growth Plans
Nov 14 REGN 2 Top Growth Stocks to Buy on the Dip
Nov 13 REGN Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
Nov 13 ARQT Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
Nov 13 APGE Apogee reports Q3 EPS, expects cash to fund operations into Q1 of 2028
Nov 13 REGN Regeneron to Highlight Pioneering Pipeline Progress Across Multiple Modalities Spanning 10 Types of Blood Cancers and Disorders at ASH
Nov 12 APGE Apogee Therapeutics reports Q3 results
Nov 12 APGE Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results
Nov 11 REGN Regeneron Announces Investor Conference Presentations
Nov 11 ARQT Wall Street Analysts See a 70.33% Upside in Arcutis Biotherapeutics (ARQT): Can the Stock Really Move This High?
Dermatitis

Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These diseases are characterized by itchiness, red skin and a rash. In cases of short duration, there may be small blisters, while in long-term cases the skin may become thickened. The area of skin involved can vary from small to the entire body.Dermatitis is a group of skin conditions that includes atopic dermatitis, allergic contact dermatitis, irritant contact dermatitis and stasis dermatitis. The exact cause of dermatitis is often unclear. Cases may involve a combination of irritation, allergy and poor venous return. The type of dermatitis is generally determined by the person's history and the location of the rash. For example, irritant dermatitis often occurs on the hands of people who frequently get them wet. Allergic contact dermatitis occurs upon exposure to an allergen, causing a hypersensitivity reaction in the skin.Treatment of atopic dermatitis is typically with moisturizers and steroid creams. The steroid creams should generally be of mid- to high strength and used for less than two weeks at a time as side effects can occur. Antibiotics may be required if there are signs of skin infection. Contact dermatitis is typically treated by avoiding the allergen or irritant. Antihistamines may help with sleep and to decrease nighttime scratching.Dermatitis was estimated to affect 245 million people globally in 2015. Atopic dermatitis is the most common type and generally starts in childhood. In the United States, it affects about 10–30% of people. Contact dermatitis is twice as common in females than males. Allergic contact dermatitis affects about 7% of people at some point in time. Irritant contact dermatitis is common, especially among people who do certain jobs; exact rates are unclear.

Browse All Tags